In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates.

F. Hagen; M.T. Ilnait-zaragozi; K.H. Barlett; D. Swinne; E. Geertsen; C.H. Klaassen; T. Boekhout; J.F. Meis

In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates.

Translated title of the contribution: In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates.

F. Hagen, M.T. Ilnait-zaragozi, K.H. Barlett, D. Swinne, E. Geertsen, C.H. Klaassen, T. Boekhout, J.F. Meis

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates.
Original language	Undefined/Unknown
Pages (from-to)	5139-5154
Number of pages	7
Journal	Antimicrobial Agents and Chemotherapy
Volume	54
Issue number	12
Publication status	Published - 2010

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/20855729

Cite this

Hagen, F., Ilnait-zaragozi, M. T., Barlett, K. H., Swinne, D., Geertsen, E., Klaassen, C. H., Boekhout, T., & Meis, J. F. (2010). In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates. Antimicrobial Agents and Chemotherapy, 54(12), 5139-5154. http://www.ncbi.nlm.nih.gov/pubmed/20855729

@article{90ede3e08f99444683244f08c73869b8,

title = "In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates.",

author = "F. Hagen and M.T. Ilnait-zaragozi and K.H. Barlett and D. Swinne and E. Geertsen and C.H. Klaassen and T. Boekhout and J.F. Meis",

year = "2010",

language = "Undefined/Unknown",

volume = "54",

pages = "5139--5154",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "12",

}

Hagen, F, Ilnait-zaragozi, MT, Barlett, KH, Swinne, D, Geertsen, E, Klaassen, CH, Boekhout, T & Meis, JF 2010, 'In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates.', Antimicrobial Agents and Chemotherapy, vol. 54, no. 12, pp. 5139-5154. <http://www.ncbi.nlm.nih.gov/pubmed/20855729>

In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates. / Hagen, F.; Ilnait-zaragozi, M.T.; Barlett, K.H. et al.
In: Antimicrobial Agents and Chemotherapy, Vol. 54, No. 12, 2010, p. 5139-5154.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates.

AU - Hagen, F.

AU - Ilnait-zaragozi, M.T.

AU - Barlett, K.H.

AU - Swinne, D.

AU - Geertsen, E.

AU - Klaassen, C.H.

AU - Boekhout, T.

AU - Meis, J.F.

PY - 2010

Y1 - 2010

M3 - Article

SN - 0066-4804

VL - 54

SP - 5139

EP - 5154

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

IS - 12

ER -